MCMedicalCodingSoftware
E13.3313

E13.3313Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral

Billable / specific codeICD-10-CM

E13.3313 is a billable, specific ICD-10-CM code for other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral. It is valid for submission on a claim.

7th character "3" — bilateral

One of the following 7th characters is to be assigned to codes in subcategory E13.33 to designate laterality of the disease:

1
right eye
2
left eye
3
bilateral
9
unspecified eye

Excludes1 inherited from the categories above E13.3313

These are not written on E13.3313, but they bind it: a note on a category applies to every code beneath it. Billing E13.3313 with anything listed here is a denial.

Written on E13 Other specified diabetes mellitus

  • diabetes (mellitus) due to autoimmune process (E10.-)
  • diabetes (mellitus) due to immune mediated pancreatic islet beta-cell destruction (E10.-)
  • diabetes mellitus due to underlying condition (E08.-)
  • drug or chemical induced diabetes mellitus (E09.-)
  • gestational diabetes (O24.4-)
  • neonatal diabetes mellitus (P70.2)
  • type 1 diabetes mellitus (E10.-)

Other codes that can never be billed with E13.3313

These codes carry an Excludes1 note pointing at E13.3313. The conflict binds both ways, but ICD-10-CM only writes it down on one side — so you would not find this by reading E13.3313 alone.

  • E10Type 1 diabetes mellitus
  • E11Type 2 diabetes mellitus
  • E09Drug or chemical induced diabetes mellitus
  • E08Diabetes mellitus due to underlying condition

Risk adjustment

E13.3313 risk-adjusts. Under the CMS-HCC V28 model it maps to these categories:

  • HCC 37 Diabetes with Chronic Complications0.166 RAF
  • HCC 298 Severe Diabetic Eye Disease, Retinal Vein Occlusion, and Vitreous Hemorrhage0.336 RAF

Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.

Medicare coverage

E13.3313 is named in 58 Medicare coverage policies 57 listing it as supporting medical necessity, and 1 listing it as NOT covered. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.

  • A57069Billing and Coding: Ophthalmic Angiography (Fluorescein and Indocyanine Green)not covered
  • A52370Billing and Coding: Bevacizumab and biosimilars
  • A52451Billing and Coding: Ranibizumab, Aflibercept and biosimilars
  • A52451Billing and Coding: Ranibizumab, Aflibercept and biosimilars

Code history

E13.3313 has not changed since FY2024 — no addition, revision or deletion across the three most recent ICD-10-CM releases.

Related codes at this level

Codes that share E13.331. If E13.3313 is not quite right, the correct code is usually one of these.

Questions about E13.3313

Is E13.3313 a billable ICD-10-CM code?
Yes. E13.3313 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
Where does E13.3313 sit in the tabular list?
Endocrine, nutritional and metabolic diseases (E00-E89), in the block Diabetes mellitus (E08-E13).
What cannot be coded together with E13.3313?
E13.3313 carries Excludes1 notes, which means the conditions they list can never be coded together with it on the same encounter. Some are written on the categories above E13.3313 (E13) and apply to it just the same.
ICD-10-CMFY2026-Apr· effective April 1, 2026

Loaded directly from the CMS/NCHS ICD-10-CM public-domain release — see data sources and our editorial policy. If this page disagrees with the CMS tabular list, this page is wrong. Reference information for professional coders; not medical or billing advice.